Better light gives lift to dementia patients: study

CHICAGO (Reuters) - Brightening the lights for elderly people with dementia, in combination with a daily dose of the sleep

Silence may be appropriate trauma response for some

NEW YORK (Reuters Health) - People who don't talk about their feelings after a traumatic event are no more likely

J&J, Schering arthritis drug effective in trials

NEW YORK (Reuters) - An experimental treatment for rheumaid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared

Benefit small from lung cancer screening method

WASHINGTON (Reuters) - A high-tech X-ray called a spiral CT scan may help reduce lung cancer deaths in smokers and

St. John's wort doesn't help ADHD, study finds

WASHINGTON (Reuters) - The herb St. John's wort does not improve children's symptoms of attention-deficit hyperactivity disorder, according to researchers

Tools


WITNESS: Amid chaos, Nepal's king bows out gracefully Adoption system seen failing kids from minorities Rocker and rapper up for top Broadway honors Sean Connery to unveil autobiography at festival Amy Winehouse in Russia billionaire gig Inflation fear sends mortgage rates to 8 month high Invitrogen to buy Applied Biosystems for $6.7 bln Corn sets record high as floods hit U.S. crops GM Europe chief sees sales slumping Lehman demotes key executives after surprise loss

Populair


Microsoft's standards bid stalled Your say Big headache Gritty Sweden beat holders Greece Villa hits hat-trick as Spain crush Russia Better light gives lift to dementia patients: study Adoption system seen failing kids from minorities Inflation fear sends mortgage rates to 8 month high Amy Winehouse in Russia billionaire gig Rocker and rapper up for top Broadway honors

Daiichi to pay up to $4.6 billion for control of Ranbaxy

| Print |

E-mail

TOKYO/NEW DELHI (Reuters) - Japanese maker Daiichi Sankyo Co Ltd moved to take majority control of India's biggest

TOKYO/NEW DELHI (Reuters) - Japanese drug maker Daiichi Sankyo Co Ltd moved to take majority control of India's biggest drug maker Ranbaxy Laboratories Ltd in a friendly deal worth up to $4.6 billion.

Source: Reuters.com

Sections

Health


Adoption system seen failing kids from minorities WITNESS: Amid chaos, Nepal's king bows out gracefully Southern hemisphere wine gaining in global market Saying "I do" on top of Sydney's Harbor Bridge Ninjas and Legos a good summer start for gamers

Lifestyle


Bears release running back Cedric Benson Rays select shortstop Beckham with No. 1 draft pick League to auction game-worn jerseys during finals Title showdown pits Lakers offense against Celtics defense Woods in upbeat mood for Torrey Pines after knee surgery

Fashion


Men's Shoes Store - stylish footwear for your guy Oscar fashion - red carpet celebrity photos The Secret of French Chic, plus video Best Handbags Shopping Guide - We've add new designer bag styles Paris Chic - The iconic Ray-Ban Wayfarer Sunglasses

World News


Microsoft's standards bid stalled Your say Big headache Gritty Sweden beat holders Greece Villa hits hat-trick as Spain crush Russia

Technology


Records Retention: Practice What You Preach Startup Of The Week: Embotics Tech Road Map: IF-MAP Protocol Apple Previews Its Next Mac OS 'Snow Leopard' iPhone 3G Analysis: Apple's Big Tease

Business


Inflation fear sends mortgage rates to 8 month high Invitrogen to buy Applied Biosystems for $6.7 bln Corn sets record high as floods hit U.S. crops GM Europe chief sees sales slumping Big U.S. banks have tightened loan standards: survey

Sport


Better light gives lift to dementia patients: study J&J, Schering arthritis drug effective in trials Silence may be appropriate trauma response for some St. John's wort doesn't help ADHD, study finds Benefit small from lung cancer screening method